A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Iradimed Corp stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 8,707 shares of IRMD stock, worth $469,568. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,707
Previous 8,767 0.68%
Holding current value
$469,568
Previous $385,000 13.51%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$43.23 - $50.29 $2,593 - $3,017
-60 Reduced 0.68%
8,707 $437,000
Q2 2024

Jul 19, 2024

SELL
$40.36 - $44.7 $6,376 - $7,062
-158 Reduced 1.77%
8,767 $385,000
Q1 2024

Apr 17, 2024

BUY
$41.17 - $47.29 $156,075 - $179,276
3,791 Added 73.84%
8,925 $392,000
Q4 2023

Jan 10, 2024

BUY
$37.31 - $47.47 $191,549 - $243,710
5,134 New
5,134 $243,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $678M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.